Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$41.2 - $73.6 $6.85 Million - $12.2 Million
-166,145 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$59.15 - $91.99 $4.65 Million - $7.23 Million
78,645 Added 89.88%
166,145 $10.5 Million
Q2 2021

Aug 16, 2021

BUY
$63.02 - $95.11 $5.51 Million - $8.32 Million
87,500 New
87,500 $8.01 Million
Q1 2019

May 15, 2019

SELL
$22.09 - $39.21 $8.8 Million - $15.6 Million
-398,337 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$19.89 - $30.02 $7.92 Million - $12 Million
398,337 New
398,337 $10 Million
Q3 2018

Nov 14, 2018

SELL
$12.1 - $28.85 $2.63 Million - $6.28 Million
-217,557 Closed
0 $0
Q2 2018

Aug 14, 2018

SELL
$7.93 - $15.79 $5.1 Million - $10.2 Million
-643,143 Reduced 74.72%
217,557 $2.66 Million
Q1 2018

May 15, 2018

BUY
$5.18 - $7.97 $4.46 Million - $6.86 Million
860,700 New
860,700 $6.86 Million

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.33B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Polar Asset Management Partners Inc. Portfolio

Follow Polar Asset Management Partners Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Polar Asset Management Partners Inc., based on Form 13F filings with the SEC.

News

Stay updated on Polar Asset Management Partners Inc. with notifications on news.